To better accommodate important updates in the screening guidelines for HPV, an infection present in 20 million people in the United States and resulting in 6.2 million new infections per year, Mayo Medical Laboratories now offers testing for the detection of high-risk HPV (hrHPV), with genotyping for HPV-16 and HPV-18.
Advantages of this new test:
- 3 -in-1 testing for every sample: High-risk HPV detection (14 high-risk types) with specific genotyping for HPV-16 and HPV-18
- Enables women with positive results for HPV-16 and/or HPV-18 to be referred to colposcopy right away
- Performed on cervical/endocervical and vaginal samples collected in ThinPrep or SurePath media
Learn more about HPV testing at Mayo Medical Laboratories.